Anticoagulant Therapy in Difficult Patients with Atrial Fibrillation: When the Risks of Embolism and Bleeding Are Comparable

This article affects  the problems of using NOAC in the most defenseless groups  of patients with atrial fibrillation: those  who have high bleeding and high thromboembolic risk and elderly. The focus is on comparison of effectiveness and safety of NOACs based  on randomized clinical trials (RCT) an...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: D. A. Napalkov, A. A. Sokolova, M. A. Gabitova, L. N. Uddin
Формат: Artigo
Язык:Inglês
Опубликовано: Stolichnaya Izdatelskaya Kompaniya 2018-11-01
Серии:Racionalʹnaâ Farmakoterapiâ v Kardiologii
Предметы:
atrial fibrillation
difficult patients
elderly
rivaroxaban
warfarin
Online-ссылка:https://www.rpcardio.com/jour/article/view/1769
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы